Endogenous nitric oxide attenuates β-adrenoceptor-mediated relaxation in rat aorta

Clinical and Experimental Pharmacology and Physiology

Volumn 34, Issue 1-2, 2007, Pages 95-101

  Kang, Khong Bee ^a   Van Der Zypp, Andrea ^a   Majewski, Henryk ^a  

^a RMIT UNIVERSITY   (Australia)

Author keywords

adrenoceptors; Aorta; cAMP; cGMP; Endothelium; Nitric oxide; Vasorelaxation

Indexed keywords

ADENOSINE 3',5' PHOSPHOROTHIOATE; BETA ADRENERGIC RECEPTOR; CYCLIC AMP; CYCLIC GMP; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; TETRYLAMMONIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM; ENZYME ACTIVITY; HEART MUSCLE RELAXATION; MALE; NONHUMAN; RAT; SMOOTH MUSCLE RELAXATION; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ADRENERGIC BETA-AGONISTS; ANIMALS; AORTA, THORACIC; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; ISOPROTERENOL; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; OMEGA-N-METHYLARGININE; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA; TETRAETHYLAMMONIUM; THIONUCLEOTIDES; VASODILATION;

EID: 33846101550     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04536.x     Document Type: Article

References (47)

1. Massion PB, Balligand JL. Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): Lessons from genetically modified mice. J. Physiol. 2003; 546: 63-75.
2. Barouch LA, Harrison RW, Skaf MW et al. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 2002; 416: 337-9.2.
3. Colyer J. Phosphorylation states of phospholamban. Ann. N.Y. Acad. Sci. 1998; 853: 79-91.
4. Fiscus RR, Rapaport RM, Waldman SA, Murad F. Atriopeptin II elevates cyclic GMP, activates cyclic GMP-dependent protein kinase and causes relaxation in rat thoracic aorta. Biochim. Biophys. Acta 1985; 846: 179-84.
5. Huggins JP, Cook EA, Piggott JR, Mattinsley TJ, England PJ. Phospholamban is a good substrate for cyclic GMP-dependent protein kinase in vitro, but not in intact cardiac or smooth muscle. Biochem. J. 1989; 260: 829-35.
6. Li H, Liu JP, Robinson PJ. Multiple substrates for cGMP-dependent protein kinase from bovine aortic smooth muscle: Purification of P132. J. Vasc. Res. 1996; 33: 99-110.
7. Li H, Liu JP, Smith R, Robinson PJ. Identification of cGMP-dependent protein kinase and its specific substrates in the anterior pituitary. Mol. Cell. Endocrinol. 1996; 122: 159-71.
8. Komalavilas P, Lincoln TM. Phosphorylation of the inositol 1,4,5-trisphosphate receptor. Cyclic GMP-dependent protein kinase mediates cAMP and cGMP dependent phosphorylation in the intact rat aorta. J. Biol. Chem. 1996; 271: 21 933-8.
9. Nishikawa M, De Lanerolle P, Lincoln TM, Adelstein RS. Phosphorylation of mammalian myosin light chain kinases by the catalytic subunit of cyclic AMP-dependent protein kinase and by cyclic GMP-dependent protein kinase. J. Biol. Chem. 1984; 259: 8429-36.
10. Giembycz MA, Raeburn D. Putative substrates for cyclic nucleotide-dependent protein kinases and the control of airway smooth muscle tone. J. Auton. Pharmacol. 1991; 11: 365-98.
11. +-channel activity in tracheal myocytes by phosphorylation. Nature 1989; 341: 152-4.
12. White RE, Kryman JP, El-Mowafy AM, Han G, Carrier GO. cAMPdependent vasodilators cross-activate the cGMP-dependent protein kinase to stimulate BK(Ca) channel activity in coronary artery smooth muscle cells. Circ. Res. 2000; 86: 897-905.
13. Francis SH, Noblett BD, Todd BW, Well JN, Corbin JD. Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinase. Mol. Pharmacol. 1988; 34: 506-17.
14. Jiang H, Colbran JL, Francis SH, Corbin JD. Direct evidence for crossactivation of cGMP-dependent protein kinase by cAMP in pig coronary arteries. J. Biol. Chem. 1992; 267: 1015-19.
15. Wolfe L, Corbin JD, Francis SH. Characterization of a novel isozyme of cGMP-dependent protein kinase from bovine aorta. J. Biol. Chem. 1989; 264: 7734-41.
16. Murthy KS, Zhou H, Makhlouff GM. PKA-dependent activation of PDE3A and PDE4 and inhibition of adenylyl cyclase V/VI in smooth muscle. Am. J. Physiol. Cell Physiol. 2002; 282: C508-17.
17. Eckly-Michel A, Martin V, Lugnier C. Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation. Br. J. Pharmacol. 1997; 122: 158-64.
18. Delpy E, Coste H, Gouville AC. Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: Role of phosphodiesterase 3. Br. J. Pharmacl 1996; 119: 471-8.
19. Lugnier C, Keravis T, Eckly-Michel A. Cross talk between NO and cyclic nucleotide phosphodiesterases in the modulation of signal transduction in blood vessel. J. Physiol. Pharmacol. 1999; 50: 639-52.
20. Muskalek P, Rigg L, Terrar DA, Paterson DJ, Casadei B. Role of cGMP-inhibited phosphodiesterase and sarcoplasmic calcium in mediating the increase in basal heart rate with nitric oxide donors. J. Mol. Cell. Cardiol. 2000; 32: 1831-40.
21. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature 1988; 333: 664-6.
22. Botelho LH, Rothermel JD, Coombs RV, Jastorff B. cAMP analog antagonists of cAMP action. Methods Enzymol. 1988; 159: 159-72.
23. Rothermel JD, Perillo NL, Marks JS, Botelho LH. Effects of the specific cAMP antagonist, (Rp)-adenosine cyclic-3′,5′-phosphorothioate, on the cAMP-dependent protein kinase-induced activity of hepatic glycogen phosphorylase and glycogen synthase. J. Biol. Chem. 1984; 259: 15 294-300.
24. Gu ZF, Jensen RT, Maton PN. A primary role for protein kinase A in smooth muscle relaxation induced by adrenergic agonists and neuropeptides. Am. J. Physiol. 1992; 263: G360-4.
25. Perez-Vallina JR, Revuelta MP, Cantabrana B, Hidalgo A. Effect of Rp diastereoisomer of adenosine 3′,5′-cyclic-monophosphothioate on the cAMP-dependent relaxation of smooth muscle. Life Sci. 1997; 61: 869-80.
26. Gray DW, Marshall I. Novel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vasorelaxation in rat thoracic aorta. Br. J. Pharmacol. 1992; 107: 684-90.
27. Iranami H, Hatano Y, Tsukiyama Y, Maeda H, Mizumoto K. A beta-adrenoceptor agonist evokes a nitric oxide-cGMP relaxation mechanism modulated by adenylyl cyclase in rat aorta. Halothane does not inhibit this mechanism. Anesthesiology 1996; 85: 1129-38.
28. Moncada S, Rees DD, Schulz R, Palmer RM. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc. Natl Acad. Sci. USA 1991; 88: 2166-70.
29. Van Der Zypp A, Kang KB, Majewski H. Age-related involvement of the endothelium in beta-adrenoceptor-mediated relaxation of rat aorta. Eur. J. Pharmacol. 2000; 397: 129-38.
30. Satake N, Shibata M, Shibata S. The inhibitory effects of iberiotoxin and 4-aminopyridine on the relaxation induced by beta 1- and beta 2-adrenoceptor activation in rat aortic rings. Br. J. Pharmacol. 1996; 119: 505-10.
31. Penn RB, Parent JL, Pronin AN, Panettieri RA, Benovic JL. Pharmacological inhibition of protein kinases in intact cells: Antagonism of beta adrenergic receptor ligand binding by H-89 reveals limitations of usefulness. J. Pharmacol. Exp. Ther. 1999; 288: 428-37.
32. Van der Zypp A, Majewski H. Effect of cGMP inhibitors on the actions of nitrodilators in rat aorta. Clin. Exp. Pharmacol. Physiol. 1998; 25: 38-43.
33. Jiang H, Shabb JB, Corbin JD. Cross-activation: Overriding cAMP/cGMP selectivities of protein kinases in tissues. Biochem. Cell Biol. 1992; 70: 1283-9.
34. 2+ by cAMP in vascular smooth muscle cells. Am. J. Physiol. 1990; 258: C399-407.
35. Priest RM, Hucks D, Ward JP. Potentiation of cyclic AMP-mediated vasorelaxation by phenylephrine in pulmonary arteries of the rat. Br. J. Pharmacol. 1999; 127: 291-9.
36. Priest RM, Hucks D, Ward JP. Noradrenaline, beta-adrenoceptor mediated vasorelaxation and nitric oxide in large and small pulmonary arteries of the rat. Br. J. Pharmacol. 1997; 122: 1375-84.
37. Chung S, Soh H, Uhm D. Beta-adrenergic modulation of maxi-K channels in vascular smooth muscle via Gi through a membrane-delimited pathway. Pflügers Arch. 1999; 37: 508-10.
38. Scornik FS, Codina J, Birnbaumer L, Toro L. Modulation of coronary smooth muscle KCa channels by Gs alpha independent of phosphorylation by protein kinase A. Am. J. Physiol. 1993; 265: H1460-5.
39. Rose RJ, Liu H, Palmer D, Maurice DH. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity. Br. J. Pharmacol. 1997; 122: 233-40.
40. Eckly AE, Lugnier C. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway. Br. J. Pharmacol. 1994; 113: 445-50.
41. Toyoshima H, Nasa Y, Hashizumi Y et al. Modulation of cAMP-mediated vasorelaxation by endothelial nitric oxide and basal cGMP in vascular smooth muscle. J. Cardiovasc. Pharmacol. 1998; 32: 543-51.
42. Jones RL, Qian Y, Wong HN, Chan H, Yim AP. Prostanoid action on the human pulmonary vascular system. Clin. Exp. Pharmacol. Physiol. 1997; 24: 969-72.
43. Sadoshima J, Akaike N, Kanaide H, Nakamura M. Cyclic AMP modulates Ca-activated K channels in cultured smooth muscle cells of rat aortas. Am. J. Physiol. 1988; 255: H754-9.
44. Dumas JP, Giorand F, Bardou M et al. Role of potassium channels and nitric oxide in the relaxant effects elicited by beta-adrenoceptor agonists on hypoxic vasoconstriction in the isolated perfused lung of the rat. Br. J. Pharmacol. 1999; 127: 421-8.
45. + channels in smooth muscle cells of guinea-pig mesenteric lymphatics: Role in nitric oxide and beta-adrenoceptor agonist-induced hyperpolarizations. Br. J. Pharmacol. 1998; 125: 17-22.
46. Brayden JE. Potassium channels in vascular smooth muscle. Clin. Exp. Pharmacol. Physiol. 1996; 23: 1069-76.
47. + channel by cyclic AMP in cultured porcine coronary artery smooth muscle cells. Life Sci. 1993; 53: 1129-35.